• By ICR Secretariat
  • Posted Wednesday, April 5, 2023

GSK plays defense after California judge approves plaintiff's expert testimony in high-stakes Zantac trial


After eluding thousands of federal lawsuits because a U.S. district judge rejected the science behind plaintiffs’ claims, GSK will be forced to defend itself against allegations that its fallen heartburn med Zantac causes cancer in state court this summer.